Effectiveness of statins in patients with stroke due to cervical artery dissection: A preliminary study.

BACKGROUND Statin therapy has become one of the most important advances in stroke secondary prevention. Nevertheless, statin therapy in patients who present an ischemic stroke following cervical artery dissection (CAD) has not yet been supported by clinical evidence. This study aimed to investigate the effect of statins on neurological outcomes after a stroke due to CAD. METHODS We conducted a prospective cohort study including consecutive patients diagnosed with a stroke due to CAD. Subjects were classified into non-statin, simvastatin 20mg, simvastatin 40mg, and high-potency statin groups. After 2 years, the functional outcome, stroke recurrence, major cardiovascular events, and mortality were assessed. RESULTS Among the 54 patients included in our cohort, there were 16 (29.6%) patients without statins, 22 (40.7%) with simvastatin 20mg, 12 (22.2%) with simvastatin 40mg and 4 (7.5%) with high-potency statins. Using simvastatin 40mg was associated with a significantly lower incidence of stroke recurrence. Patients with simvastatin 40mg and high-potency statins presented the best functional recovery throughout the follow-up (p<.01). DISCUSSION The use of statins in patients with CAD-related stroke may improve functional outcomes in specific cases. Statins do not prevent stroke recurrence and major cardiovascular events in this type of stroke.

• Publication year

  2020

• Venue

  Medicina clínica (Ed. impresa)

• Publication date

  2020-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.medcli.2020.06.056PMID 32826077
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The influence of statins on the risk of post-stroke epilepsy

  2020cited by this paper
• Use of CHADS2 and CHA2DS2-VASc scores to predict prognosis after stroke.

  2020cited by this paper
• Outcomes of pregnant women with refractory epilepsy.

  2019cited by this paper
• Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis

  2019cited by this paper
• Statins in Ischemic Stroke Prevention: What Have We Learned in the Post-SPARCL (The Stroke Prevention by Aggressive Reduction in Cholesterol Levels) Decade?

  2019cited by this paper
• Medication Adherence of Statin Users after Acute Ischemic Stroke

  2018cited by this paper
• Characteristics and Outcomes of Vertebrobasilar Artery Dissection with Accompanied Atherosclerosis

  2017cited by this paper
• Effects of Statin Intensity and Adherence on the Long-Term Prognosis After Acute Ischemic Stroke

  2017cited by this paper
• Treatment of Cervical Artery Dissection: Antithrombotics, Thrombolysis, and Endovascular Therapy

  2017cited by this paper
• Relationship between dyslipidemia and vascular repair after cervical artery dissection

  2016cited by this paper
• Gender differences and woman-specific trends in acute stroke: results from a hospital-based registry (1986-2009).

  2014cited by this paper
• Advancements in understanding the mechanisms of symptomatic lacunar ischemic stroke: translation of knowledge to prevention strategies

  2014cited by this paper
• Cervical Arterial Dissections and Association With Cervical Manipulative Therapy: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

  2014cited by this paper
• Effect of statin drugs on thoracic aortic aneurysms.

  2013cited by this paper
• Statin Therapy and Outcome After Ischemic Stroke: Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials

  2013cited by this paper
• High-dose statins should only be used in atherosclerotic strokes.

  2012cited by this paper
• Statins for acute ischemic stroke.

  2011cited by this paper
• Cervical-artery dissections: predisposing factors, diagnosis, and outcome.

  2009cited by this paper
• Drug Class Review: HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin: Final Report Update 5

  2009cited by this paper
• Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival

  2009cited by this paper
• The beneficial effect of statins treatment by stroke subtype

  2009cited by this paper
• Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention.

  2009cited by this paper
• Vascular risk factors and morphometric data in cervical artery dissection: a case-control study

  2009cited by this paper
• Discontinuation of Statin Therapy and Clinical Outcome After Ischemic Stroke

  2007cited by this paper
• Incidence and outcome of cervical artery dissection: a population-based study.

  2007cited by this paper
• Statin treatment withdrawal in ischemic stroke

  2007cited by this paper
• High-dose atorvastatin after stroke or transient ischemic attack.

  2006cited by this paper
• The dynamics of statins: from event prevention to neuroprotection.

  2006cited by this paper
• High-dose atorvastatin after stroke or transient ischemic attack.

  2006cited by this paper
• Incidence and outcome of cervical artery dissection

  2006cited by this paper
• Differences between hypertensive and non‐hypertensive ischemic stroke

  2004cited by this paper
• Risk of stroke and recurrent dissection after a cervical artery dissection

  2003cited by this paper
• Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke

  2002cited by this paper

• Preliminary results of pravastatin on non-hemorrhagic vertebral artery dissection: an exploratory randomized and controlled study

  2025cites this paper
• Statin Use in Cervical Artery Dissection and Subsequent Ischemic Stroke

  2025cites this paper
• Evolving Clinical–Translational Investigations of Cerebroprotection in Ischemic Stroke

  2023cites this paper
• Effectiveness of statins on outcomes of patients with Embolic Stroke of Undetermined Source (ESUS).

  2023cites this paper
• Atorvastatin for unruptured intracranial vertebrobasilar dissecting aneurysm (ATREAT-VBD): protocol for a randomised, double-blind, blank-controlled trial

  2022cites this paper